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Abstract
Background: Although pneumococcal pneumonia is one of the most common causes of death due to
infectious diseases, little is known about pneumococci-lung cell interaction. Herein we tested the
hypothesis that pneumococci activated pulmonary epithelial cell cytokine release by c-Jun-NH2-terminal
kinase (JNK)
Methods: Human bronchial epithelial cells (BEAS-2B) or epithelial HEK293 cells were infected with S.
pneumoniae  R6x and cytokine induction was measured by RT-PCR, ELISA and Bioplex assay. JNK-
phosphorylation was detected by Western blot and nuclear signaling was assessed by electrophoretic
mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP). JNK was modulated by the small
molecule inhibitor SP600125 and AP1 by transfection of a dominant negative mutant.
Results: S. pneumoniae induced the release of distinct CC and CXC, as well as Th1 and Th2 cytokines and
growth factors by human lung epithelial cell line BEAS-2B. Furthermore, pneumococci infection resulted
in JNK phosphorylation in BEAS-2B cells. Inhibition of JNK by small molecule inhibitor SP600125 reduced
pneumococci-induced IL-8 mRNA expression and release of IL-8 and IL-6. One regulator of the il8
promoter is JNK-phosphorylated activator protein 1 (AP-1). We showed that S. pneumoniae time-
dependently induced DNA binding of AP-1 and its phosphorylated subunit c-Jun with a maximum at 3 to
5 h after infection. Recruitment of Ser63/73-phosphorylated c-Jun and RNA polymerase II to the
endogenous il8 promoter was found 2 h after S. pneumoniae infection by chromatin immunoprecipitation.
AP-1 repressor A-Fos reduced IL-8 release by TLR2-overexpressing HEK293 cells induced by
pneumococci but not by TNFα. Antisense-constructs targeting the AP-1 subunits Fra1 and Fra2 had no
inhibitory effect on pneumococci-induced IL-8 release.
Conclusion: S. pneumoniae-induced IL-8 expression by human epithelial BEAS-2B cells depended on
activation of JNK and recruitment of phosphorylated c-Jun to the il8 promoter.
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Background
Pneumonia is the most common cause of death due to
infectious diseases in industrialized countries [1]. Over 40
% of all cases are due to Streptococcus pneumoniae, which is
the most frequent etiologic agent of community-acquired
pneumonia [2,3]. Despite the availability of vaccines and
antibiotic treatments, mortality rates remain high [2,4].
Importantly, the number of antibiotic resistant strains is
increasing and even vancomycin-tolerant strains have
been observed [5].
Cytokine liberation and subsequent recruitment and acti-
vation of leucocytes are a hallmark in pneumococci pneu-
monia usually leading to elimination of the pathogens.
Although immune cells like alveolar macrophages signifi-
cantly contribute to the activation of the host immune sys-
tem, evidence has been presented that lung epithelium
considerably participates in the recognition of invading
pathogens and initiation of the host response [6]. Since
the pulmonary epithelium constitutes a large surface,
which is in direct contact with invading pathogens, analy-
sis of the interaction between pathogens and pulmonary
epithelial cells is of considerable interest.
Host cell activation by S. pneumoniae involved membrane-
bound pattern recognition receptors TLR2 [7,8]and TLR4
[8,9]. Moreover, we recently demonstrated that cytosolic
Nod2 protein [10] recognized invading, cytosolic pneu-
mococci. Pneumococci infection of lung epithelial cells
initiated complex signaling pathways leading to activa-
tion of the canonical NF-κB pathway and subsequent
expression of pro-inflammatory genes. Activation of
mitogen-activated protein kinase (MAPK) pathways par-
ticipated in lung cell activation by pneumococci. For
example, p38 MAPK activation induced phosphorylation
of NF-κB p65/RelA at serine 536 at the interleukin-8 (IL-
8) promoter thus paving the way for RNA polymerase II
recruitment, and subsequent IL-8 transcription in pneu-
mococci infected epithelium [11]. In addition, stimula-
tion of c-Jun N-terminal kinase/stress-activated protein
kinase JNK/SAPK kinase was shown in pneumococci
infected cells [12]. In other model systems, JNK was
shown to subsequently activate transcription factor activa-
tor protein-1 (AP-1) [13], a central regulator of cytokine
expression, by phosphorylating its component c-Jun on
serine 63 and serine 73 in the NH2-terminal activation
domain [14,15].
In this study, we analyzed the liberation of different
cytokines families as well as of growth factors by pneumo-
cocci infected BEAS-2B cells and tested the role of the JNK
kinase pathway for cytokine liberation by using IL-8 as a
model cytokine.
Pneumococci induced liberation of a broad array of
chemo- and cytokines as well as growth factors. S. pneumo-
niae  infection resulted in JNK phosphorylation, and
increased AP-1-DNA-binding in BEAS-2B cells. Inhibition
of JNK reduced pneumococci-induced IL-8 mRNA expres-
sion and release of IL-8 and IL-6. In addition, recruitment
of Ser63/73-phosphorylated c-Jun and RNA polymerase II
to the endogenous il8 promoter was found after S. pneu-
moniae infection by chromatin immunoprecipitation. AP-
1 repressor A-Fos reduced IL-8 release induced by pneu-
mococci but not by TNFα. In contrast, antisense-con-
structs targeting the AP-1 subunits Fra1 and Fra2 had no
inhibitory effect on pneumococci-induced IL-8 release. In
conclusion, JNK-and AP-1-dependent activation of lung
epithelial BEAS-2B cells lead to expression of IL-8.
Materials and methods
Materials
DMEM, FCS, trypsin-EDTA-solution, CA-650, and antibi-
otics were obtained from Life Technologies (Karlsruhe,
Germany). TNFα was purchased from R&D Systems
(Wiesbaden, Germany). All other chemicals used were of
analytical grade and obtained from commercial sources.
Cell lines
Human bronchial epithelial BEAS-2B cells were a kind gift
of C. Harris (NIH, Bethesda, MD) [16]. Human embry-
onic kidney cells (HEK293) were purchased from ATCC
(Rockville, USA).
Bacterial strains
S. pneumoniae R6x is the unencapsulated derivative of type
2 strain D39 [17]. Single colony isolates of R6x were
maintained at 37°C with 5% CO2 on Columbia agar with
5% sheep blood. For cell culture stimulation studies, sin-
gle colonies were expanded by resuspension in Todd-
Hewitt broth supplemented with 0.5% yeast extract and
incubation at 37°C for 3 – 4 h to midlog phase (A600 0.2
– 0.4), harvested by centrifugation and resuspended in
cell culture medium at the indicated concentration with-
out antibiotics as described [11]. Cell viability was vali-
dated by microscopy and measurement LDH release into
the supernatant.
Plasmids, and transient transfection procedures
HEK293 cells were cultured in 12-well plates with DMEM
supplemented with 10% FCS. Subconfluent cells were co-
transfected by using Superfect (Qiagen, Hilden, Germany)
according to the manufacturer's instructions (Clonetech,
Palo Alto, USA) with 0.1 μg of hTLR2 (generously pro-
vided by Tularik Inc., San Francisco, USA [18]) and dom-
inant-negative A-Fos (kind gift of Dr. Charles Vinson,
NCI, NIH, Rockville, MD) [19], or Fra1- or Fra2-antisense
(kind gift of Dr. Vladimir Berezin, Institute of Molecular
Pathology, School of Medicine, Copenhagen University,Respiratory Research 2006, 7:98 http://respiratory-research.com/content/7/1/98
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Copenhagen, Denmark) [20] expression vectors or con-
trol vector. Cells were incubated with R6x for 6 h.
IL-6 and IL-8 ELISA
Confluent BEAS-2B cells were stimulated for 15 h in a
humidified atmosphere. After incubation supernatants
were collected. In some experiments, cells were lysed with
mellitin for 30 min [21]. Supernatants and lysates were
processed for IL-6 or IL-8-quantification by sandwich-
ELISA as described previously [8].
Bioplex protein array system
Confluent BEAS-2B cells were infected for 15 h with pneu-
mococci as indicated in a humidified atmosphere. After
incubation supernatants were collected and cytokine
release was analyzed with the Bioplex Protein Array sys-
tem (BioRad, Hercules, CA) using beads specific for IL-2,
IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17,
MCP-1, TNFα, IL-1β, IFNγ, GM-CSF and MIP-1β, accord-
ing to the manufacturers instructions as described previ-
ously [20].
RT-PCR
For analysis of IL-8 and GAPDH gene expression in BEAS-
2B cells total RNA was isolated with RNEasy Mini kit
(Quiagen, Hilden, Germany) and reverse transcribed
using AMV reverse transcriptase (Promega, Heidelberg,
Germany). Generated cDNA was amplified by PCR using
specific intron-spanning specific primers for IL-8 and
GAPDH. All primers were purchased from TIB MOLBIOL,
Berlin, Germany. After 35 amplification cycles, PCR prod-
ucts were analyzed on 1.5 % agarose gels, stained with
ethidium bromide and subsequently visualized. To con-
firm use of equal amounts of RNA in each experiment, all
samples were checked for GAPDH mRNA expression [11].
Western Blot
For determination of JNK phosphorylation, BEAS-2B cells
were infected as indicated, washed twice, and harvested.
Cells were lysed in buffer containing Triton X-100, sub-
jected to SDS-PAGE and blotted on Hybond-ECL mem-
brane (Amersham Biosciences, Freiburg, Germany).
Immunodetection of phosphorylated JNK was carried out
with phospho-specific JNK antibody (Cell Signaling,
Frankfurt, Germany) [12]. In all experiments, actin (Santa
Cruz Biotechnologies, Santa Cruz, CA) was detected
simultaneously to confirm equal protein load. Proteins
were visualized by incubation with secondary IRDye 800-
or Cy5.5-labeled antibodies, respectively, and quantified
by Licor Odyssey software (Odyssey infrared imaging sys-
tem, LI-COR Inc.) [10,11].
Electrophoretic mobility shift assay (EMSA)
After stimulation of BEAS-2B cells nuclear protein was iso-
lated and analyzed by EMSA as described previously [22-
24]. IRDye800-labeled consensus AP-1 oligonucleotides
(GTC AGT CAG TGA CTC AAT CGG TCA) were purchased
from Metabion, Planegg-Martinsried, Germany. Briefly,
EMSA binding reactions were performed by incubating
7.5 μg of nuclear extract with the annealed oligos accord-
ing to the manufacturer's instructions. The reaction mix-
ture was subjected to electrophoresis on a 5% native gel
and analyzed by Odyssey infrared imaging system (LI-
COR Inc.).
P-c-Jun Transcription factor assay assay (Trans AM™)
The P-c-Jun TransAM™ Assay (Active Motif, Carlsbad, CA)
was used to detect DNA binding of P-c-Jun containing AP-
1 dimers according to the manufacturer's instructions.
Briefly, BEAS-2B cells were stimulated, and 10 μg of
nuclear cell extract (containing activated transcription fac-
tor) were given in oligonucleotide-coated wells. After 20
min of incubation at room temperature with mild agita-
tion, the plate was washed, and 100 μl/well of the diluted
P-c-Jun antibody (1:1000) was incubated for 1 h. The
plate was washed 3 times and 100 μl HRP-conjugated
antibody (1:1000) was added for 1 h. Developing solu-
tion was incubated for 10 min. The reaction was stopped
and absorbance was read at 450 nm.
Chromatin immunoprecipitation
BEAS-2B cells were stimulated, culture medium was
removed and 1% formaldehyde was added. After 1 min,
cells were washed in ice-cold 0.125 M glycin in PBS and
then rapidly collected in ice cold PBS, centrifuged and
washed twice with ice cold PBS as described previously
[11]. Cells were lysed in RIPA buffer (10 mM Tris (pH
7.5), 150 mM NaCl, 1% NP-40, 1% desoxycholic acid,
0.1% SDS, 1 mM EDTA, 1% aprotinin) and the chromatin
was sheared by sonication. Lysates were cleared by centrif-
ugation and supernatants were stored in aliquots at -80°C
until further use. Antbodies were purchased from Santa
Cruz Biotechnology, Santa Cruz, CA (P-c-Jun and Pol II).
Immunoprecipitations from soluble chromatin were car-
ried out overnight at 4°C. Immune complexes were col-
lected with protein A/G agarose for 60 min and washed
twice with RIPA Buffer, once with high-salt buffer (2 M
NaCl, 10 mM Tris pH 7.5, 1% NP-40, 0.5% desoxycholic
acid, 1 mM EDTA) followed by another wash in RIPA
Buffer and one wash with TE Buffer (10 mM Tris (pH 7.5),
1 mM EDTA). Immune complexes were extracted in elu-
tion buffer (1 TE Buffer containing 1% SDS) by shaking
the lysates for 15 min at 1200 rpm, 30°C. They were then
digested with RNAse (1 μg/20 μl) for 30 min at 37°C.
After proteinase K digestion (1 μg/8 μl for 6 h at 37°C and
6 h at 65°) DNA was extracted using a PCR purification kit
(Qiagen, Hilden, Germany). il8  promoter DNA was
amplified by PCR using Hotstart Taq (Qiagen) polymer-
ase. The PCR conditions were 95°C for 15 min, 33 – 35
cycles of 94°C for 20 s, 60°C for 20 s, 72°C for 20 s. PCRRespiratory Research 2006, 7:98 http://respiratory-research.com/content/7/1/98
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products were separated by agarose gel electrophoresis
and detected by ethidium bromide staining. Equal
amounts of input DNA was controlled by gel electro-
phoresis.
The following il8  promoter-specific primers were used:
sense 5'-AAG AAA ACT TTC GTC ATA CTC CG-3'; anti-
sense 5'-TGG CTT TTT ATA TCA TCA CCC TAC-3' [11].
Statistical methods
Data are shown as means ± SEM of at least three inde-
pendent experiments. A one-way ANOVA was used for
data of Fig. 1, 2B, 2D, 3B, and 4. Data are shown as means
± SEM of at least three separate experiments. Main effects
were then compared by a Newman-Keuls' post-test. P <
0.01 was considered to be significant and indicated by
asterisks.
Results
S. pneumoniae induced cytokine release in human lung 
epithelial BEAS-2B cells
To characterize the inflammatory activation of human
lung epithelial cells by S. pneumoniae, we infected BEAS-
2B cell with pneumococci strain R6x with an infection
dose of 106 cfu/ml. Cytokine release was analyzed using a
Bioplex-assay. After 5, 10, and 20 h of incubation, we
observed significant induction of MCP-1, GM-CSF, IFNγ,
IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 (p70), IL-13, IL-17,
MIP1β, and TNFα (Fig. 1). IL-1β was found only after 10
and 20 h of infection, and IL-7 level was elevated only
S. pneumoniae induce the release of distinct CC and CXC, as well as Th1 and Th2 cytokines and growth factors by human lung  epithelial cells Figure 1
S. pneumoniae induce the release of distinct CC and CXC, as well as Th1 and Th2 cytokines and growth factors by human lung 
epithelial cells. BEAS-2B cells were infected with S. pneumoniae strain R6x (106 cfu/ml) for 5, 10, or 20 h. Cytokine release in 
the supernatant was measured by Bioplex assay. *, p < 0.01 vs. uninfected control, #, p < 0.01 one time point vs. another, at 
least in three independent experiments.Respiratory Research 2006, 7:98 http://respiratory-research.com/content/7/1/98
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after 5 h. Significant time-dependent increase was found
for GM-CSF, IFNγ, IL-1β, IL-4, IL-12 (p70), IL-17 and
TNFα, whereas IL-6 displayed highest protein level after 5
h of pneumococci exposure.
S. pneumoniae induced c-Jun-NH2-terminal kinase-
dependent IL-8 release in human lung epithelial BEAS-2B 
cells
IL-8 is an important chemotactic cytokine in lung inflam-
mation [6] and an established model cytokine for signal
transduction analysis [11,25,26] and neutrophil recruit-
ment depended on JNK in different models of acute lung
injury [14,27]. In S. pneumoniae-infected BEAS-2B cells,
we detected JNK2 phosphorylation starting at 30 min post
infection (Fig. 2A). After 4 h, pneumococci induced JNK2
phosphorylation similar to TNFα. Inhibition of JNK by
specific chemical inhibitor SP600125 dose-dependently
reduced S. pneumoniae-induced IL-8 protein release (Fig.
2B) and levels of IL-8 mRNA (Fig. 2C) in human lung epi-
thelial BEAS-2B cells. Exemplarily, release of the impor-
tant inflammatory cytokine IL-6 was also analyzed in cells
with inhibited JNK kinase (Fig. 2D). 10 ng/ml of JNK
inhibitor SP600125 reduced pneumococci-induced IL-6
release by 50 % (Fig. 2D), while 1 ng/ml had no signifi-
cant effect (data not shown). Infection with pneumococci
or inhibition of JNK with SP600125 did not influence
intracellular levels of IL-8 or IL-6 within the timeframe
studied (data not shown).
S. pneumoniae induce DNA binding of AP-1 in human 
lung epithelial BEAS-2B cells
IL-8 gene transcription is in part regulated by JNK-
dependent activation of AP-1 in granulocytes [25] as well
as lung epithelial cells [28,29]. We found AP-1 DNA-bind-
ing after 2, 4, and 7 h of pneumococci infection in human
lung epithelial cells (Fig. 3A). 4 h of infection were similar
potent in AP-1 activation as 1 h of TNFα stimulation with
10 ng/ml. No activated AP-1 was found 30 min after S.
pneumoniae infection. Moreover, by using a transcription
factor assay kit, we observed DNA binding of phosphor-
ylated AP-1-subunit c-Jun 2 and 4 h after pneumococci-
infection of BEAS-2B cells (Fig. 3B). Next we specifically
addressed the il8 promoter by chromatin immunoprecip-
itation (ChIP). 2 h after S. pneumoniae-infection of human
lung epithelial cells, Ser63/73-phosphorylated c-Jun and
RNA polymerase II (Pol II) were recruited to the endog-
enous il8 promoter (Fig. 3C).
S. pneumoniae induced AP-1-dependent IL-8 release in 
human epithelial BEAS-2B cells
To verify importance of transcription factor AP-1 on pneu-
mococci-induced IL-8 release, we made use of HEK293
cells transiently transfected with human toll-like receptor
2 (TLR2). After 15 h of pneumococci infection or stimula-
tion with TNFα, IL-8 release could be detected in the
S. pneumoniae induced JNK-dependent IL-8 and IL-6 release  by human lung epithelial cells Figure 2
S. pneumoniae induced JNK-dependent IL-8 and IL-6 release 
by human lung epithelial cells. (A) BEAS-2B cells were 
infected with 106 cfu/ml S. pneumoniae R6x for the times and 
JNK2 phosphorylation was detected by Western blot. A rep-
resentative of three independent experiments is shown and 
quantification of all three experiments is given. (B/D) BEAS-
2B cells were preincubated with the indicated concentrations 
of JNK inhibitor SP600125 and then infected with 106 cfu/ml 
S. pneumoniae R6x for 15 h. IL-8 (B) and IL-6 (D) concentra-
tions were measured in the supernatant. *, p < 0.01 vs. con-
trol; #, p < 0.01 vs. infected cells without pre-incubation with 
inhibitors in three independent experiments. (C) BEAS-2B 
cells were preincubated with the indicated concentrations of 
JNK inhibitor SP600125 and then infected with 106 cfu/ml S. 
pneumoniae R6x for 3 h. IL-8 and GAPDH mRNA was 
detected by RT-PCR. Representative gels of three independ-
ent experiments are shown.Respiratory Research 2006, 7:98 http://respiratory-research.com/content/7/1/98
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supernatant (Fig. 4). HEK293-TLR2 cells were cotrans-
fected with A-Fos (CMV500-A-Fos), a superrepressor of c-
Jun-containg AP-1 dimers [19], or empty vector
(CMV500). A-Fos strongly reduced pneumococci-, but not
TNFα-induced IL-8 release. Antisense constructs for AP-1
subunits Fra1 or Fra2 [20] had no inhibitory effect on IL-
8 release by HEK293-TLR2 cells.
Discussion
Although S. pneumoniae is the major pathogen of commu-
nity-acquired pneumonia [30], little is known about its
interaction with target cells, and particularly, with lung
epithelial cells [31]. Infection of the human tracheobron-
chial epithelial cell line BEAS-2B with pneumococci
resulted in release of a broad panel of regulatory cyto-,
chemokines and growth factors. For example, strong
release of the chemoattractants IL-8 (polymorphonuclear
neutrophils) and MCP-1 (monocytes) was found. In addi-
tion, Th1 cytokines IFNγ and TNFα, as well as Th2
cytokines like IL-4, IL-6, and IL-13 were released after
pneumococci infection. Prominent secretion of the pro-
inflammatory cytokine IL-1β was observed as well as lib-
eration of myeloid growth factors G-CSF and IL-7. Inter-
estingly, in addition to pro-inflammatory factors,
infection of BEAS-2B cells with pneumococci resulted also
in production of anti-inflammatory IL-10. This pattern of
immunomodulatory factors released by cultured lung epi-
thelial BEAS cells in vitro may indicate that activation of
tracheobronchial epithelial cells by pneumococci in vivo
impact on immune reaction in pneumococcal infection.
Furthermore, the lung epithelium express membrane
bound PRRs (e.g. TLR) [32] as well as cytosolic receptors
(e.g. NACHT-LRR protein Nod2) [10], suitable for the
detection of invading pneumococci. Taken these facts in
consideration, the lung epithelium may function as an
important sentinel system for the detection of lung path-
ogens rather than only comprising a "passive" epithelial
barrier.
Thus, we decided to investigate molecular pathways
underlying this cytokine response in more detail by using
IL-8 as a model cytokine, which is known to be an impor-
tant chemoattractant in the lung [6]: We observed a time-
dependent phosphorylation of JNK – thereby indicating
activation – in pneumococci-exposed epithelium. Moreo-
ver, JNK inhibition by the chemical inhibitor SP600125
reduced pneumococci-related IL-8 mRNA expression and
cytokine release (IL-8, IL-6), while intracellular IL-8 and
IL-6 levels remained unchanged. Although other bacteria
causing pneumonia, such as Legionella pneumophila were
shown to activate JNK in human monocytotic cells [33],
there are no further studies analyzing JNK activation after
infection of pulmonary epithelial cells with bacteria. In
rodent models, current studies suggest an important role
of JNK for the regulation of lung inflammation besides
pneumococci infection. Lipopolysaccharide-related pul-
monary neutrophil influx e.g. was limited by inhibition of
JNK [34] and this kinase played an important role in ven-
tilation-induced neutrophil infiltration [27]. Moreover,
JNK seems to be important for the regulation of the viabil-
AP-1 repressor blocked S. pneumoniae-induced IL-8 release Figure 4
AP-1 repressor blocked S. pneumoniae-induced IL-8 release. 
HEK293 cells were transfected with plasmids encoding TLR2, 
as well as empty vector (CMV500), AP-1 repressor 
(CMV500-A-Fos), Fra1 antisense (AS Fra1), or Fra2 antisense 
(AS Fra2), respectively. Then, cells were infected with S. 
pneumoniae strain R6x (105 cfu/ml) or stimulated with TNFα 
(50 ng/ml) for 15 h, and IL-8 concentration was measured in 
the supernatant. *, p < 0.01 vs. control; #, p < 0.01 vs. 
infected cells with empty vector at least in three independent 
experiments.
S. pneumoniae induced AP-1 activation in human lung epithe- lial cells Figure 3
S. pneumoniae induced AP-1 activation in human lung epithe-
lial cells. BEAS-2B cells were infected with S. pneumoniae R6x 
(106 or 107 cfu/ml as indicated) (A/B/C) for the indicated 
times or TNFα (50 ng/ml, 0.5 h). DNA binding of AP-1 (A) 
was detected by EMSA and of phosphorylated c-Jun by tran-
scription factor activation assay (B). *, p < 0.01 vs. control. 
Recruitment of Ser63/73-phosphorylated c-Jun and RNA 
polymerase II to the endogenous il8 promoter was detected 
by chromatin immunoprecipitation (C). Representatives of at 
least three independent experiments are shown.Respiratory Research 2006, 7:98 http://respiratory-research.com/content/7/1/98
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ity of lung epithelium after exposure to active nitrogen
species [35]. Although JNK is known to be stimulated by
many different types of cellular stress, such as UV, γ -irra-
diation and pathogen infection, it is reasonable to suggest,
that TLR- or Nod-related signaling mediates JNK activa-
tion by pneumococci. However, it could not be ruled out
that oxidative stress induced by pneumococci-released
hydrogen peroxide contributed to JNK activation. Overall,
pneumococci-related JNK activation may be an important
signaling step in the pneumococci-host interaction proc-
ess.
Phosphorylation of the transcription factor c-Jun on ser-
ine-63 and serine-73 in its N-terminal transactivation
domain by activated JNK augments c-Jun transcriptional
activity [36,37]. The AP-1 transcription factor is mainly
composed of Jun, Fos and ATF protein dimers [38,39]. We
found increased AP-1 DNA-binding after pneumococci
infection of human lung epithelial cells in EMSA as well
as increased DNA binding of phosphorylated AP-1-subu-
nit c-Jun in a specific ELISA demonstrating AP-1 transcrip-
tion factor activation. Next, we specifically addressed the
il8 promoter by ChIP and noted recruitment of Ser63/73-
phosphorylated c-Jun and Pol II to the endogenous il8
promoter after S. pneumoniae-infection of human lung
epithelial cells. In addition, expression of CMV500-A-Fos,
a superrepressor of c-Jun-containing AP-1 dimers [19],
strongly reduced pneumococci-, but not TNFα-induced
IL-8 release verifying the central role of JNK-AP-1 for
pneumococci-related IL-8 expression. In contrast to A-Fos,
Fra1 and Fra2 proteins – which lack potent transactivation
domains – seems not to be involved in pneumococci
induced IL-8 expression as evidenced by experiments
using antisense constructs for Fra1 or Fra2 [40,41].
However, Tchilibon et al. recently implicated phospho-c-
JUN/c-FOS dimers in TNFα-related IL-8 expression in
cystic fibrosis lung epithelial cells IB-3 and IB-3/S9 by
using MRS2481, a compound inhibiting both signaling of
the NF-κB and the AP-1 pathway [42]. In addition, in
16HBE14o-human bronchial epithelial cells TNF-α-
induced chemokine expression may be dependent on
stimulation of AP-1 pathway [43]. Since our results
according the role of the superrepressor CMV500-A-Fos in
TNFα-related cell activation were obtained in HEK293
cells, cell- and stimulus-specific effects could not be ruled
out.
Overall, pneumococci induced AP-1 activation may con-
tribute significantly to pneumococci-related IL-8 release
by pulmonary epithelium.
A central role for JNK in the expression of IL-8 in lung epi-
thelial cells was also reported by Wu et al. who demon-
strated JNK-dependent IL-8 expression in the type-II-like
alveolar cell line A549 after proteasome inhibition [44].
In addition, stretching of these cells also resulted in JNK-
AP-1 dependent IL-8 expression [45]. Although analyzing
non-lung cell lines, He et al. provided evidence that severe
acute respiratory syndrome (SARS) coronavirus CoV
nucleocapsid activated c-Fos suggesting that, besides bac-
teria, viruses may also induce JNK-AP-1-dependent gene
transcription in the lung [46].
However, although cumulating evidence suggests an
important role of the JNK-AP-1 signaling pathway in lung
inflammation, including pneumococcal pneumonia, sev-
eral questions remain open. For example, the capability of
other important lung pathogens like Legionella, viruses or
fungi to activate the JNK-AP-1 pathway should be ana-
lyzed. In vivo experiments addressing the effect of JNK
inhibitors in pneumonia models would help to estimate
the therapeutic potential of such inhibitors in lung
inflammation. Finally, it would be of interest to analyze
these signaling pathways in different human primary pul-
monary epithelial cells (e.g. small airways, type-I-, type-II-
cells).
In this study, we have shown that pneumococci strongly
activated secretion of different cytokine families as well as
growth factors by BEAS-2B cells. By analyzing IL-8 expres-
sion in detail, we demonstrated a central role of the JNK-
AP-1 signaling pathway for pneumococci-induced IL-8
liberation by human pulmonary epithelial BEAS-2B cells.
Therefore, it is reasonable to suggest that pulmonary epi-
thelial cell could actively participate in immune response
in pneumococcal infection.
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